Literature DB >> 25707344

Parathyroid hormone, calcium, and sodium bridging between osteoporosis and hypertension in postmenopausal Korean women.

Jee Soo Park1, Soo Beom Choi, Yumie Rhee, Jai Won Chung, Eui-Young Choi, Deok Won Kim.   

Abstract

The coexistence of osteoporosis and hypertension, which are considered distinct diseases, has been widely reported. In addition, daily intake of calcium and sodium, as well as parathyroid hormone levels (PTH), is known to be associated with osteoporosis and hypertension. This study aimed to determine the association of low calcium intake, high sodium intake, and PTH levels with osteoporosis and hypertension in postmenopausal Korean women. Data for postmenopausal Korean women aged 50 years or older were obtained from the Korea National Health and Nutrition Examination Survey 2008-2011. Osteoporosis was diagnosed using dual energy X-ray absorptiometry, while hypertension was diagnosed using blood pressure data. The odds ratios for osteoporosis and hypertension were calculated using logistic regression analysis for quartiles of the daily calcium intake, daily sodium intake, and PTH levels. Women with hypertension had a high coexistence of osteoporosis (43.6 vs. 36.5 %; P = 0.022), and vice versa (21.1 vs. 16.6 %; P = 0.022). PTH was significantly associated with osteoporosis and hypertension, and a high intake of calcium was strongly correlated with a low incidence of osteoporosis. This is the first study to report the characteristics of postmenopausal Korean women who have high dietary sodium intake and low dietary calcium intake, in association with the incidence of osteoporosis and hypertension. Osteoporosis and hypertension were strongly associated with each other, and PTH appears to be a key mediator of both diseases, suggesting a possible pathogenic link.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25707344     DOI: 10.1007/s00223-015-9972-x

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  5 in total

1.  Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet: a retrospective cross-sectional study.

Authors:  L Zhou; J Song; S Yang; S Meng; X Lv; J Yue; A Mina; B Puchi; Y Geng; L Yang
Journal:  Osteoporos Int       Date:  2017-02-02       Impact factor: 4.507

2.  Meta-analysis of hypertension and osteoporotic fracture risk in women and men.

Authors:  C Li; Y Zeng; L Tao; S Liu; Z Ni; Q Huang; Q Wang
Journal:  Osteoporos Int       Date:  2017-04-26       Impact factor: 4.507

3.  A cross-sectional study to evaluate the associations between hypertension and osteoporosis in Chinese postmenopausal women.

Authors:  Jin Zhang; Keqin Zhang; Haiming Shi; Zihui Tang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

4.  Less Vertebral Bone Mass after Treatment with Macitentan in Mice: A Pilot Study.

Authors:  Zhong-Yu Liu; Man-Ting Au; Tian-Wei He; Bu Yang; Bin Liu; Liang-Ming Zhang; Chun-Xiao Luo; Li-Min Rong; Chun-Yi Wen
Journal:  Biomed Res Int       Date:  2019-02-19       Impact factor: 3.411

5.  Determining the association between hypertension and bone metabolism markers in osteoporotic patients.

Authors:  Zhuoqing Hu; Kevin Yang; Zhihui Hu; Miaosheng Li; Hao Wei; Zheng Tang; Baitong Chen; Chengbiao Su; Jinrong Xu
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.